---
title: "ACCMEDE PHARMACEUTICALS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/7909c573-c24e-5a41-a0b9-e1d6afba6dcb
json: https://whiteintel.dev/api/public/dossier/7909c573-c24e-5a41-a0b9-e1d6afba6dcb
identifier: oo:GB-COH-08881762
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ACCMEDE PHARMACEUTICALS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-08881762`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/7909c573-c24e-5a41-a0b9-e1d6afba6dcb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/7909c573-c24e-5a41-a0b9-e1d6afba6dcb  

## Ownership & control

### Owners / controllers

- **Janaksinh Jhala** (beneficial owner) — 50% — https://whiteintel.dev/entity/4597b0f3-8a1c-5261-8180-2469c62601fc
- **Mrs Kinjalben Barot** (beneficial owner) — 100% — https://whiteintel.dev/entity/1fa48114-719f-504e-9186-431c88cf039b
- **Janaksinh Jhala** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/1dc75c69-b77f-4ef5-863d-ba6881224a1e
- **Mrs Kinjalben Barot** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/0ae83ccc-ca8c-433c-9a4b-c5cf21107511

### UBO chain (walk to the ultimate owner)

A **4-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `08881762`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2014-02-07
- **Registered office:** Unit B4, 142 Johnson Street, Southall, Middlesex, UB2 5FD, England
- **SIC:** 46420, 46499, 46650, 47910

### Officers

- BAROT, Kinjalben — director · Indian · appointed 2020-09-22
- GOHIL, Arjunsinh — director · Indian · appointed 2014-02-07 · resigned 2020-06-01
- JHALA, Janaksinh — director · British · appointed 2020-07-13 · resigned 2020-10-13
- JHALA, Janaksinh — director · Indian · appointed 2014-02-26 · resigned 2020-06-01
- PANDYA, Shamkaushal Devendrabhai — director · Indian · appointed 2020-06-01 · resigned 2020-07-13

### Beneficial owners (Persons with Significant Control)

- Mrs Kinjalben Barot — 75–100% shares · individual PSC · United Kingdom — since 2020-09-22
- Janaksinh Jhala — 25–50% shares · individual PSC · England — ceased 2020-06-01

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08881762
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08881762

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ACCMEDE PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/7909c573-c24e-5a41-a0b9-e1d6afba6dcb · Structured JSON: https://whiteintel.dev/api/public/dossier/7909c573-c24e-5a41-a0b9-e1d6afba6dcb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._